Curcumin and Retinal Study

Recruiting now · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Bioavailability, Gut Microbiome, Safety

In brief

To test how two weeks of curcumin supplementation would cross the blood brain barrier (BBB) and attach to amyloid beta proteins, to assess the feasibility (safety and bioavailability), and to explore the resulting abundance/composition of gut microbiota.

Key facts

Study ID
NCT05774704
Run by
Texas Tech University Health Sciences Center
People needed
60
Starts
2023-08-21
Expected to finish
2026-12-31
Last updated by the study team
2026-01-13

Who can join

Age: 40 and older, up to 89. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.